Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Published:2012-10 Issue:1 Volume:127 Page:70-74
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Schilder Russell J.,Brady William E.,Lankes Heather A.,Fiorica James V.,Shahin Mark S.,Zhou Xun C.,Mannel Robert S.,Pathak Harsh B.,Hu Wei,Alpaugh R. Katherine,Sood Anil K.,Godwin Andrew K.

Funder

The University of Kansas Cancer Center

Kansas Bioscience Authority Eminent Scholar Program

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference34 articles.

1. Recent progress in the diagnosis and treatment of ovarian cancer;Jelovac;CA Cancer J Clin,2011

2. Src in cancer: deregulation and consequences for cell behaviour;Frame;Biochim Biophys Acta,2002

3. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancer;Wiener;Gynecol Oncol,2003

4. A renaissance for SRC;Yeatman;Nat Rev Cancer,2004

5. Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line;Pengetnze;Biochem Biophys Res Commun,2003

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells;Translational Oncology;2024-06

2. Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies;Journal of Immunotherapy and Precision Oncology;2024-02-01

3. Ascites in malignant ovarian cancer confer ovarian cancer cells chemoresistance to platinum. Combination treatment with crizotinib and 2-hydroxyestradiol restores platinum sensitivity;2023-09-24

4. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283;Gynecologic Oncology;2023-09

5. Molecular principles of tissue invasion and metastasis;American Journal of Physiology-Cell Physiology;2023-05-01